Rheonix Lectures in China on Its Innovative Molecular Platform
ITHACA, N.Y. Rheonix, Inc., a developer of fully automated molecular testing solutions, recently spoke at Beijing University of Chemical Technology, School of Information and Technology. Dr....
View ArticleTEAC Introduces UR-4MD: It’s Never Been So Easy to Capture & Reliably Store...
TOKYO TEAC Corporation (hereinafter TEAC) (TOKYO:6803), the world leader in medical imaging, recording and filing solutions, today announced a new high-definition medical imaging recorder to be...
View ArticleAsfotase Alfa Granted Orphan Drug Designation in Japan
CHESHIRE, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to asfotase alfa for...
View Articleアブダビ警察が10月に包括的医療会議を開催
アラブ首長国連邦アブダビ (ビジネスワイヤ) — 10月16日にアブダビで包括的医療会議が開催され、専門医が集まります。医師らは、女性の健康および内科、産婦人科、皮膚科疾患予防の推進と強化について話し合います。また、あらゆる年齢層の女性にとって最適な医療の提供に重点を置きます。...
View Article阿布扎比警察局将于10月举办综合医学会议
阿联酋阿布扎比 (美国商业资讯)–定于10月16日在阿布扎比举行的综合医学大会(Comprehensive Medical Conference)将吸引众多专业医师的参加。医生们将讨论如何改善和增强女性健康,以及如何预防内科疾病、妇产科疾病和皮肤病。他们还将重点关注如何为各个年龄段的女性提供最佳的医疗保健服务。...
View ArticleKonica Minolta & NineSigma Launch Contest for Service Innovation on...
TOKYO NineSigma Japan (www.ninesigma.co.jp/), representing Konica Minolta, Inc. (www.konicaminolta.com/), seeks an idea that will enable “service innovation” built on their newly developed input...
View ArticleFitgenes Takes Part in Largest Healthcare Information Technology Event in...
BRISBANE, Australia Australian integrated healthcare company, Fitgenes (ASX:FIT) is pleased to announce it will be attending the largest healthcare Information Technology conference and exhibition...
View ArticleRheonix在中国开讲,介绍其创新分子平台
纽约州伊萨卡 (美国商业资讯)–全自动分子检测解决方案的开发者Rheonix, Inc.最近在北京化工大学信息技术学院发表演讲。Rheonix高级研究工程师Zongyuan Chen博士为70位研究生和教职员工介绍了体外诊断(IVD)市场,深入介绍了Rheonix的突破性平台EncompassMDxTM。据《IVD...
View ArticleNexvet Expands Australian Veterinary Biologics Research Centre
MELBOURNE, Australia Veterinary biologic therapy developer Nexvet Biopharma today announced that Dr. Samantha Busfield, PhD, and Dr. Dallas Hartman, PhD, two senior biopharmaceutical research and...
View ArticleSignificant Study of Cluster Dextrin® Now Available from Glico
OSAKA, Japan In 2013, Glico conducted in vivo human clinical trials with Cluster Dextrin® (Highly Branched Cyclic Dextrin / HBCD). The attendant theses were reviewed, and consequently accepted for...
View ArticleBeiGene Receives Clinical Milestone Payment for Development of BGB-290
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the achievement of a clinical milestone in the...
View ArticleCigna Foundation Global Grant Supports Crowdfunding for Surgeries in India
BLOOMFIELD, Conn. & CHENNAI, India The Cigna Foundation today announced a $100,000 World of Difference grant to Samahope – a crowdfunding platform that allows anyone, anywhere to directly fund...
View Article昆泰推出新客户解决方案以满足新兴生物制药公司的独特需求
北卡罗来纳州三角研究园 (美国商业资讯)–昆泰公司(Quintiles)认识到新兴生物制药公司在全球市场所发挥的关键作用,于今日推出昆泰新兴生物制药解决方案(Quintiles Emerging Biopharma Solution),从而进一步扩充其解决方案套件。该解决方案是一款旨在满足新兴生物制药公司特殊的临床发展需求和目标的新产品。 昆泰临床开发总裁Paula Brown...
View ArticleParata Systems Showcases Pharmacy Technology Solutions at HIMSS AsiaPac14...
DURHAM, N.C. Parata Systems, a leading provider of pharmacy technology solutions to support coordinated care, better health outcomes and lower medical costs, announced today that it is exhibiting at...
View Articleクインタイルズが新興バイオ製薬企業の独自ニーズに対応する新しい顧客ソリューションをリリース
米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ) — クインタイルズは、世界市場で新興バイオ製薬企業が果たす極めて重要な役割を認識していることから、クインタイルズ・エマージング・バイオファーマ・ソリューション(Quintiles Emerging Biopharma...
View ArticleCovidien宣布两项神经血管临床试验开始入组患者
爱尔兰都柏林 (美国商业资讯)–Covidien plc今天宣布,两项临床试验开始入组患者,这两项试验旨在进一步强调该公司先进的神经血管解决方案的安全性和疗效。 佛罗里达州杰克逊维尔的浸信会医疗中心治疗了入组PREMIER前瞻性研究的首例患者,该研究是国际性研究性器械豁免(IDE)临床研究,旨在评估Pipeline™栓塞器械用于较小的未破裂颅内动脉瘤。另外,肯塔基州...
View ArticleSun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab
WHITEHOUSE STATION, N.J., and MUMBAI, India Merck & Co., Inc., (NYSE:MRK), known as MSD outside the United States and Canada, and Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg:...
View Articleコヴィディエンが神経血管分野の臨床試験2件への患者組み入れ開始を発表
アイルランド・ダブリン (ビジネスワイヤ) — コヴィディエンは本日、当社の先進的な神経血管ソリューションの安全性と有効性を一層明らかにするための臨床試験2件で、患者組み入れの開始を発表しました。...
View ArticleNew Data Presented at EASD Demonstrate Robust Cardiometabolic Health Effects...
LEXINGTON, Mass. & SYDNEY GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced new data demonstrating...
View ArticleMiraMed Continues Global Healthcare Expansion
JACKSON, Mich. MiraMed Global Services (MiraMed), headquartered in Jackson, Michigan, is pleased to announce the continuing global expansion of the MiraMed brand led by the success of its Big Data...
View Article